Cargando…
Could treatment with botulinum toxin protect against subsequent infection with COVID-19?
We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205559/ https://www.ncbi.nlm.nih.gov/pubmed/34144245 http://dx.doi.org/10.1016/j.jormas.2021.06.003 |
_version_ | 1783708527281307648 |
---|---|
author | Batifol, D. Finiels, P.J. Galmiche, S. Jammet, P. de Boutray, M. |
author_facet | Batifol, D. Finiels, P.J. Galmiche, S. Jammet, P. de Boutray, M. |
author_sort | Batifol, D. |
collection | PubMed |
description | We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and neuromodulators. The recent mention of a potential protective effect of nicotine in COVID 19, by blocking ACh, attracted our attention and guided the present study. Our results show a significant difference between the number of infected individuals in the general population and the number of patients injected with BoNT/A who showed signs of COVID 19. |
format | Online Article Text |
id | pubmed-8205559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82055592021-06-16 Could treatment with botulinum toxin protect against subsequent infection with COVID-19? Batifol, D. Finiels, P.J. Galmiche, S. Jammet, P. de Boutray, M. J Stomatol Oral Maxillofac Surg Short Communication We report comparative results, over three months, of the impact of SARS-CoV2 in our patients injected with botulinum toxin for functional purposes, compared to the general population. Botulinum neurotoxin type A (BoNT/A) is known to block acetylcholine (ACh) as well as many other neuroreceptors and neuromodulators. The recent mention of a potential protective effect of nicotine in COVID 19, by blocking ACh, attracted our attention and guided the present study. Our results show a significant difference between the number of infected individuals in the general population and the number of patients injected with BoNT/A who showed signs of COVID 19. Elsevier Masson SAS. 2022-04 2021-06-16 /pmc/articles/PMC8205559/ /pubmed/34144245 http://dx.doi.org/10.1016/j.jormas.2021.06.003 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Batifol, D. Finiels, P.J. Galmiche, S. Jammet, P. de Boutray, M. Could treatment with botulinum toxin protect against subsequent infection with COVID-19? |
title | Could treatment with botulinum toxin protect against subsequent infection with COVID-19? |
title_full | Could treatment with botulinum toxin protect against subsequent infection with COVID-19? |
title_fullStr | Could treatment with botulinum toxin protect against subsequent infection with COVID-19? |
title_full_unstemmed | Could treatment with botulinum toxin protect against subsequent infection with COVID-19? |
title_short | Could treatment with botulinum toxin protect against subsequent infection with COVID-19? |
title_sort | could treatment with botulinum toxin protect against subsequent infection with covid-19? |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205559/ https://www.ncbi.nlm.nih.gov/pubmed/34144245 http://dx.doi.org/10.1016/j.jormas.2021.06.003 |
work_keys_str_mv | AT batifold couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19 AT finielspj couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19 AT galmiches couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19 AT jammetp couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19 AT deboutraym couldtreatmentwithbotulinumtoxinprotectagainstsubsequentinfectionwithcovid19 |